Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Intermediate and Long-Term Side Effects of High- Dose Radioiodine Therapy for Thyroid Carcinoma

Christof Alexander, Jochen B. Bader, Andrea Schaefer, Carsten Finke and Carl-Martin Kirsch
Journal of Nuclear Medicine September 1998, 39 (9) 1551-1554;
Christof Alexander
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jochen B. Bader
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Schaefer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Finke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl-Martin Kirsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 9
September 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Intermediate and Long-Term Side Effects of High- Dose Radioiodine Therapy for Thyroid Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Intermediate and Long-Term Side Effects of High- Dose Radioiodine Therapy for Thyroid Carcinoma
Christof Alexander, Jochen B. Bader, Andrea Schaefer, Carsten Finke, Carl-Martin Kirsch
Journal of Nuclear Medicine Sep 1998, 39 (9) 1551-1554;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Intermediate and Long-Term Side Effects of High- Dose Radioiodine Therapy for Thyroid Carcinoma
Christof Alexander, Jochen B. Bader, Andrea Schaefer, Carsten Finke, Carl-Martin Kirsch
Journal of Nuclear Medicine Sep 1998, 39 (9) 1551-1554;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma
  • Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
  • Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma
  • Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours
  • Assessment of Salivary Gland Dysfunction after Radioiodine Therapy for Thyroid Carcinoma Using Non-Contrast-Enhanced CT: The Significance of Changes in Volume and Attenuation of the Glands
  • Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
  • Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
  • The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies
  • Reducing the Incidence of 131I-Induced Sialadenitis: The Role of Pilocarpine
  • The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
  • Is Empiric 131I Therapy Justified for Patients with Positive Thyroglobulin and Negative 131I Whole-Body Scanning Results?
  • Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer?
  • Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy
  • Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy
  • Google Scholar

More in this TOC Section

  • Radiotoxicity After Strontium-89 Therapy for Bone Metastases Using the Micronucleus Assay
  • Lymphoscintigraphy and Radioguided Biopsy of the Sentinel Axillary Node in Breast Cancer
  • Fluorine-18-Fluorodeoxyglucose PET Identification of Cardiac Metastasis Arising from Uterine Cervical Carcinoma
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire